The board of directors of LEPU ScienTech Medical Technology (Shanghai) Co., Ltd. announced that Ms. Zhang Yuxin has been re-designated from an executive Director to a non-executive Director and ceased to act as the deputy general manager and the chief technology officer of the Company with effect from March 1, 2024. Ms. Zhang joined the Group in May 2011 and has been a Director of the Company since January 29, 2021. The Board also announced that the appointment of Mr. Qiu Kejin as the head of research and development department of the valve division of the Company and Mr. Hu Jinpeng as the head of research and development department of the occluder division of the Company, with effect from March 1, 2024, respectively.

The biographical details of Mr. Qiu Kejin and Mr. Hu Jinpeng are set out below: Mr. Qiu Kejin, aged 36, joined the Group in June 2015. He was mainly engaged in the research and development of valve products in structural heart disease, and successively served as the research and development engineer, project manager and structural product manager. Mr. Qiu obtained a bachelor ' s degree in materials science and engineering from Harbin Engineering University in July 2009 and a doctoral degree in materials science from Harbin Engineering University in June 2015.

Mr. Hu Jinpeng, aged 32, joined the Group in July 2019 as the manager of the research and development department, responsible for various research and development of cardiac occluder products and management of the project team. Mr. Hu obtained a bachelor's degree in refrigeration and cryogenic technology from the University of Shanghai for Science and Technology in July 2009 and a master's degree in thermal energy and power engineering from the University of Shanghai for Science and Technology in May 2012.